DeDora Capital
MRNA icon

DeDora Capital’s Moderna MRNA Stock Holding History

DeDora Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44.8K Buy
+233
New +$25.1K 0.01% 189
2022
Q2 		– Sell
-520
Closed -$90K – 292
2022
Q1 		$90K Buy
+520
New +$87.5K 0.04% 124

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $2.62B AUM 125.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

DeDora Capital's MRNA Position: Q3 2026 in Review

DeDora Capital opened a new position in Moderna (MRNA) in Q3 2026: 233 shares worth $44.8K. The stake represents 0.01% of the portfolio and ranks #189 among its holdings. This is a return to the name: DeDora Capital previously reported a position in MRNA as recently as Q1 2022.

DeDora Capital first reported a position in MRNA in Q1 2022 and has held it in 2 quarters since. The position peaked at $90K in Q1 2022. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • DeDora Capital held 233 shares of Moderna worth $44.8K as of Q3 2026.
  • Moderna was a new DeDora Capital position in Q3 2026.
  • Moderna made up 0.01% of DeDora Capital's portfolio in Q3 2026, its #189 holding.
  • DeDora Capital first reported a position in Moderna in Q1 2022 and has held it in 2 quarters since.
  • DeDora Capital's Moderna position peaked at $90K in Q1 2022.
  • 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.